The system reported revenues of $2.9 billion for the year ended June 30, up from $2.6 billion over the same period last year. Net patient service revenues were $2.8 billion, up from $2.5 billion in 2023. Outpatient revenues increased by $149 million year over year, largely driven by the performance of its specialty and retail pharmacies, according to the report. Inpatient and physician revenues increased by $62 million and $28.5 million respectively, driven by higher volumes.
Temple reported total expenses of $2.9 billion in 2024, up from $2.6 billion last year. Salaries and employee benefit expenses totaled $1.53 billion, up from $1.46 billion in 2023. Supply and pharmaceutical costs were $672.8 million in 2024, up from $598.3 million over the same period last year.
Days of cash on hand was 124, as of June 30, down from 126 on the same date in 2023.
Temple reported a net income of $79.1 million in 2024, up from $6.3 million last year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
